Head to Head Analysis: PACS Group (PACS) vs. Its Competitors

PACS Group (NYSE:PACS – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its rivals? We will compare PACS Group to similar companies based on the strength of its institutional ownership, dividends, profitability, analyst recommendations, risk, earnings and valuation.

Insider & Institutional Ownership

56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations for PACS Group and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group 0 1 7 0 2.88
PACS Group Competitors 1879 7751 13385 833 2.55

PACS Group presently has a consensus target price of $61.33, suggesting a potential upside of 27.22%. As a group, “Healthcare Providers & Services” companies have a potential upside of 13.39%. Given PACS Group’s stronger consensus rating and higher probable upside, equities analysts clearly believe PACS Group is more favorable than its rivals.

Profitability

This table compares PACS Group and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
PACS Group 4.87% 31.98% 6.07%
PACS Group Competitors -7.87% -135.89% -1.58%

Earnings and Valuation

This table compares PACS Group and its rivals revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
PACS Group $5.71 billion $191.54 million 27.24
PACS Group Competitors $19.10 billion $301.67 million -1.69

PACS Group’s rivals have higher revenue and earnings than PACS Group. PACS Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

PACS Group has a beta of -0.14, suggesting that its stock price is 114% less volatile than the S&P 500. Comparatively, PACS Group’s rivals have a beta of 0.98, suggesting that their average stock price is 2% less volatile than the S&P 500.

Summary

PACS Group beats its rivals on 8 of the 13 factors compared.

About PACS Group

(Get Free Report)

PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.